VJHemOnc is committed to improving our service to you

COMy 2020 | Future research to improve predictive factors for smoldering myeloma

VJHemOnc is committed to improving our service to you

Irene Ghobrial

Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the focus of research over the next 5 years to improve prediction in smoldering myeloma. There will be developments in genomic, microenvironmental and epigenetic factors to add to the arsenal of clinical factors. Dynamic factors will also need to be further understood to more accurately describe the progression of the disease. This interview took place during the Controversies in Multiple Myeloma (COMy) 2020 Virtual World Congress.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter